Clinical Trials Browser

Active not recruiting × Lung Neoplasms × Afatinib × Clear all

NCT01553942 2024-11-20

Afatinib With CT and RT for EGFR-Mutant NSCLC

Phase 2 Active not recruiting

Lung Neoplasms